+ All Categories

Home > Documents > CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for...

CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for...

Date post:	15-May-2018
Category:	Documents
Upload:	trantram
View:	213 times
Download:	0 times

Download Report this document

Share this document with a friend

Embed Size (px):

15

CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 125387Orig1s000 CROSS DISCIPLINE TEAM LEADER REVIEW

Transcript

Page 1: CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for intravitreal in ... To re-evaluate the release and shelf-life specifications for aflibercept

CENTER FOR DRUG EVALUATION AND RESEARCH

APPLICATION NUMBER:

125387Orig1s000

CROSS DISCIPLINE TEAM LEADER REVIEW

Page 2: CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for intravitreal in ... To re-evaluate the release and shelf-life specifications for aflibercept

Page 3: CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for intravitreal in ... To re-evaluate the release and shelf-life specifications for aflibercept

Page 4: CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for intravitreal in ... To re-evaluate the release and shelf-life specifications for aflibercept

Page 5: CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for intravitreal in ... To re-evaluate the release and shelf-life specifications for aflibercept

Page 6: CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for intravitreal in ... To re-evaluate the release and shelf-life specifications for aflibercept

Page 7: CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for intravitreal in ... To re-evaluate the release and shelf-life specifications for aflibercept

Page 8: CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for intravitreal in ... To re-evaluate the release and shelf-life specifications for aflibercept

Page 9: CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for intravitreal in ... To re-evaluate the release and shelf-life specifications for aflibercept

Page 10: CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for intravitreal in ... To re-evaluate the release and shelf-life specifications for aflibercept

Page 11: CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for intravitreal in ... To re-evaluate the release and shelf-life specifications for aflibercept

Page 12: CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for intravitreal in ... To re-evaluate the release and shelf-life specifications for aflibercept

Page 13: CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for intravitreal in ... To re-evaluate the release and shelf-life specifications for aflibercept

Page 14: CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for intravitreal in ... To re-evaluate the release and shelf-life specifications for aflibercept

Page 15: CENTER FOR DRUG EVALUATION AND RESEARCH FOR DRUG EVALUATION AND RESEARCH ... 40 m L solution for intravitreal in ... To re-evaluate the release and shelf-life specifications for aflibercept

Recommended

Intravitreal Drugs

125418Orig1s000 - Food and Drug Administration€¦ · APPLICANT: Sanofi-aventis U.S. Inc. PRODUCT: Intravenous Aflibercept INDICATION Treatment of patients with metastatic colorectal

Anti vegf intravitreal injections

Health & Medicine

PRODUCT INFORMATION EYLEA aflibercept (rch) NAME …bayerresources.com.au/resources/uploads/PI/file10294.… · · 2017-11-23PRODUCT INFORMATION EYLEA ® aflibercept (rch) NAME

Eylea (aflibercept) Original Effective Date: 7/11/2014 Policy … · 2018-10-19 · 2016).b(13,14,15) Results of a study comparing intravitreal ranibizumab, aflibercept, and bevacizumab

Three-Dimensional Transport Model for Intravitreal and ......Retina Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection Yu Zhang,1 Hojjat Bazzazi,1

Container Closure and Delivery Considerations for Intravitreal Drug Administration · 2021. 5. 6. · product label. IVT Injection Procedure Injection site for IVT administration

Intravitreal Corticosteroid Implants MP-2 · intravitreal implants in comparison with ... ** “FDA approved drugs used for indications other than ... Intravitreal corticosteroid

EYLEA (aflibercept) Injection For Intravitreal …® (aflibercept) Injection For Intravitreal Injection ... Diabetic Macular Edema (DME) ... injection needle onto the Luer lock syringe

Efficacy of intravitreal AFlibercept injection For ...

96 Weeks Results from the VIEW 1 and VIEW 2 …VIEW 2 Studies: Intravitreal Aflibercept Injection Versus Ranibizumab for Neovascular AMD • Allen C. Ho, MD • Victor Chong, MD OBJECTIVE

Aflibercept for treating myopic choroidal neovascularisation

Efficacy and safety of brolucizumab versus aflibercept in ...

Australian Public Assessment Report for Aflibercept · This AusPAR describes the application by the sponsor, Bayer Australia Ltd, to extend the indications for Eylea ( aflibercept)

Newer nsaid's, intravitreal, immunosuppressant, fibrin

INTRAVITREAL MICRONIZED TRIAMCINOLONE VERSUS ...s499648585.mialojamiento.es/biblioteca/IVT/Intravitreal...INTRAVITREAL MICRONIZED TRIAMCINOLONE VERSUS TRIAMCINOLONE ACETONIDE: A CLINICAL

CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and

Intravitreal Aflibercept Injection for Macular Edema ...